The Wall Street Journal on Tuesday examined pharmaceutical company Wyeth's petition for FDA to investigate the sale and marketing of plant-based "compounded" hormones and the more than 40,000 e-mails and letters the agency in the last six months has received in reaction to the petition (Parker-Pope, Wall Street Journal, 5/2). [click link for full article]
(more...)